Cargando…
Downregulation of the human peripheral myelin protein 22 gene by miR-29a in cellular models of Charcot–Marie–Tooth disease
The majority of hereditary neuropathies are caused by duplication of the peripheral myelin protein 22 (PMP22) gene. Therefore, mechanisms to suppress the expression of the PMP22 gene have high therapeutic significance. Here we asked whether the human PMP22 gene is a target for regulation by microRNA...
Autores principales: | Serfecz, Jacquelyn, Bazick, Hannah, Al Salihi, Mohammed Omar, Turner, Peter, Fields, Christopher, Cruz, Pedro, Renne, Rolf, Notterpek, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920087/ https://www.ncbi.nlm.nih.gov/pubmed/31455873 http://dx.doi.org/10.1038/s41434-019-0098-z |
Ejemplares similares
-
Elevated Peripheral Myelin Protein 22, Reduced Mitotic Potential, and Proteasome Impairment in Dermal Fibroblasts from Charcot-Marie-Tooth Disease Type 1A Patients
por: Lee, Sooyeon, et al.
Publicado: (2018) -
A Novel Missense Mutation in Peripheral Myelin Protein-22 Causes Charcot-Marie-Tooth Disease
por: Li, Li-Xi, et al.
Publicado: (2017) -
How T118M peripheral myelin protein 22 predisposes humans to Charcot–Marie–Tooth disease
por: Stefanski, Katherine M., et al.
Publicado: (2022) -
Peripheral Myelin Protein 22 Gene Mutations in Charcot-Marie-Tooth Disease Type 1E Patients
por: Jung, Na Young, et al.
Publicado: (2022) -
A brief review of recent Charcot-Marie-Tooth research and priorities
por: Ekins, Sean, et al.
Publicado: (2015)